Benzinga | Jun 2, 2021 07:37AM EDT

Piper Sandler Maintains Overweight on LivaNova, Lowers Price Target to $98

Piper Sandler analyst Adam Maeder maintains LivaNova (NASDAQ:LIVN) with a Overweight and lowers the price target from $99 to $98.